CIK 0001590750
- Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 471187261
- Phone
- +1 617-272-4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Option exercise Director acquired 1,200 shares (option exercise)
- 4 Option exercise Director acquired 1,200 shares (option exercise)
- 4 Option exercise Director acquired 1,200 shares (option exercise)
- 4 Shares withheld for taxes CFO, Secretary, Treasurer gave up 66,547 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 103,160 shares (to pay taxes)
- 4 Shares withheld for taxes CFO, Secretary, Treasurer gave up 10,484 shares (to pay taxes)
- 4 Shares withheld for taxes President & CEO gave up 64,835 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 12 of 14 · 264 filings